A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumors
Clinical trial NCT02354547 · SUSPENDED
Trial details
- NCT number
- NCT02354547
- Sponsor
- SynerGene Therapeutics, Inc.
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2027-12-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.